Effect of Selenium on the Expression of High Affinity Interleukin 2 Receptors

Proceedings of the Society for Experimental Biology and Medicine

Volumn 200, Issue 1, 1992, Pages 36-43

  Roy, M ^a   Kiremidjian Schumacher, L ^a   Wishe, H I ^a   Cohen, M W ^a   Stotzky, G ^b  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; SELENIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; SELENIUM DEFICIENCY;

ANIMAL; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; SELENIUM; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026575562     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-200-43391     Document Type: Article

References (32)

1. Medina D, Morrison DG. Current ideas on selenium as a chemopreventive agent. Pathol Immunopathol Rev 7:187–198, 1988.
2. Willet WC, Polk BV, Morris JS, Stampler MJ, Pressil S, Rosner B, Taylor J. Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134, 1987.
3. Medina D. Mechanisms of selenium inhibition of tumorigenesis. J Am Coll Toxicol 5:21–26, 1986.
4. Kiremidjian-Schumacher L, Stotzky G. Selenium and immune responses. A review. Environ Res 42:277–303, 1987.
5. Talcott PA, Exon JH, Koller LD. Alteration of natural killer cell-mediated cytotoxicity in rats treated with selenium, diethylnitrosamine and ethylnitrosourea. Cancer Lett 23:313–322, 1984.
6. Meeker HC, Eskew ML, Schenchenzuber W, Scholz RW, Zarkower A. Antioxidant effects on cell-mediated immunity. J Leukocyte Biol 38:451–458, 1985.
7. Smith KA. Interleukin-2: Inception, impact, and implications. Science 240:1169–1176, 1988.
8. Cantrell DA, Smith KA. The interleukin-2 T-cell system: A new cell growth model. Science 224:1312–1316, 1984.
9. Waldman TA. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727–732, 1986.
10. Robb RJ. Conversion of low affinity interleukin-2 receptors to a high-affinity state following fusion of cell membranes. Proc Natl Acad Sci USA 83:3992–3996, 1986.
11. Cantrell DA, Smith KA. Transient expression of interleukin-2 receptors. Consequences of T-cell growth. J Exp Med 158:1895–1911, 1983.
12. Robb RJ, Green WC. Internalization of interleukin-2 is mediated by the β chain of the high affinity interleukin-2 receptor. J Exp Med 165:1201–1206, 1987.
13. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Selenium and immune cell functions. I. Effect on lymphocyte proliferation and production of interleukin-1 and interleukin-2. Proc Soc Exp Biol Med 193:136–142, 1990.
14. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Selenium and immune cell functions. II: Effect on lymphocyte-mediated cytotoxicity. Proc Soc Exp Biol Med 193:143–148,1990.
15. Spallholz JE, Collins GF, Schwartz K. A single-test-tube method for the fluorometric determination of selenium. Bioinorg Chem 9:453–459, 1978.
16. Dickstein R, Kiremidjian-Schumacher L, Stotzky G. Effects of lidocaine on the function of immunocompetent cells. II. Chronic in vivo exposure and its effects on mouse lymphocyte activation and expression of immunity. Immunopharmacol 9:127–139, 1985.
17. Robb RJ, Mayer PC, Garlick R. Retention of biological activity following radioiodination of human interleukin-2: Comparison with biosynthetically labelled growth factor in receptor binding assays. J Immunol Methods 81:15–30, 1985.
18. Brown PD, Sepulveda FV. A rabbit jejunal isolated enterocyte preparation suitable for transport studies. J Physiol 363:257–270, 1985.
19. Hancock AA, Bush EN, Stanisic D, Kyncl JJ, Lin CT. Data normalization before statistical analysis: Keeping the horse before the cart. Trends Pharm Sci 9:29–32, 1988.
20. Medina D, Morrison D, Oborn CJ. Selenium retention and inhibition of cell growth in mouse mammary epithelial cell lines in vitro. Biol Trace Elem Res 8:19–35, 1985.
21. Thuy LTB, Dukovich M, Peffer NJ, Fanci AS, Kehrl JH, Green WC. Direct activation of human resting T cells by IL-2: The role of an IL2 receptor distinct from the TAC protein. J Immunol 139:1550–1556, 1987.
22. Hattori M, Okazaki H, Ishida Y, Onuma M, Kano S, Honjo T, Minato N. Expression of murine IL-2 receptor β-chain on thymic and spleenic lymphocyte subpopulations as revealed by the IL-2 induced proliferative response in human IL-2 receptor α-chain transgenic mice. J Immunol 144:3809–3815, 1990.
23. Leonard WJ, Deeper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldman TA, Green WC. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631, 1984.
24. Hatakeyama MM, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T. Interleukin-2 receptor α chain gene: Generation of three receptor forms by cloned human α and β chain cDNAs. Science 244:551–556, 1989.
25. Audrain M, Boeffard F, Soulillou J-P, Jacques Y. Synergistic action of monoclonal antibodies directed at p 55 and p 75 chains of the human IL-2 receptor. J Immunol 146:884–892, 1991.
26. Bohnlein E, Ballard DW, Bogerd H, Peffer NJ, Lowenthal JW, Green WC. Induction of interleukin-2 receptor-gene expression is regulated by posttranslational activation of KB specific DNA binding proteins. J Biol Chem 264:8475–8478, 1989.
27. Grabstein K, Dower S, Gillis S, Urdal D, Larsen A. Expression of interleukin-2, interferon-γ, and the IL2 receptor by human peripheral blood lymphocytes. J Immunol 136:4503–4508, 1986.
28. Sayar D, Ketzinel M, Gerez L, Silberberg C, Reshef A, Kaempfer R. Expression of the human IL-2 receptor on lymphocytes involves rapid turnover of its p 55 α-subunit (TAC). J Immunol 145:2946–2949, 1990.
29. Leonard WJ, Kronke M, Peffer NJ, Depper JM, Green W. Interleukin-2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci USA 82:6281–6285, 1985.
30. Beneh D, Scheid S, Kyriakopoulos A, Hilmert H. Subcellular distribution of selenoproteins in the liver of the rat. Biochim Biophys Acta 1033:219–225, 1990.
31. Bery MJ, Bann L, Larsen RP. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349:438–440, 1991.
32. Diamond AM, Montero-Puerner Y, Lee BJ, Hatfield D. Selenocysteine inserting tRNAs are likely generated by tRNA editing. Nucleic Acid Res 18:6727, 1990.